A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital.
about
Vancomycin heteroresistance in bloodstream isolates of Staphylococcus capitisReduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implicationsActivity of AZD2563, a novel oxazolidinone, against Staphylococcus aureus strains with reduced susceptibility to vancomycin or linezolidSystematic Review and Meta-Analysis of the Epidemiology of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus IsolatesRelationship between vancomycin-resistant Staphylococcus aureus, vancomycin-intermediate S. aureus, high vancomycin MIC, and outcome in serious S. aureus infectionsDetection of Staphylococcus aureus delta-toxin production by whole-cell MALDI-TOF mass spectrometryVancomycin susceptibility within methicillin-resistant Staphylococcus aureus lineagesCeftaroline increases membrane binding and enhances the activity of daptomycin against daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus in a pharmacokinetic/pharmacodynamic model.Molecular features of heterogeneous vancomycin-intermediate Staphylococcus aureus strains isolated from bacteremic patientsDetection and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates in Canada: results from the Canadian Nosocomial Infection Surveillance Program, 1995-2006.Antimicrobial activity and spectrum of PPI-0903M (T-91825), a novel cephalosporin, tested against a worldwide collection of clinical strains.Exposure of Staphylococcus aureus to subinhibitory concentrations of β-lactam antibiotics induces heterogeneous vancomycin-intermediate Staphylococcus aureusCharacterization of heterogeneous vancomycin-intermediate resistance, MIC and accessory gene regulator (agr) dysfunction among clinical bloodstream isolates of staphyloccocus aureusEvaluation of vancomycin population susceptibility analysis profile as a predictor of outcomes for patients with infective endocarditis due to methicillin-resistant Staphylococcus aureus.Underestimation of vancomycin and teicoplanin MICs by broth microdilution leads to underdetection of glycopeptide-intermediate isolates of Staphylococcus aureus.Modulating activity of vancomycin and daptomycin on the expression of autolysis cell-wall turnover and membrane charge genes in hVISA and VISA strains.Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.Persistent catheter-related Staphylococcus aureus bacteremia after catheter removal and initiation of antimicrobial therapy.Difference in agr dysfunction and reduced vancomycin susceptibility between MRSA bacteremia involving SCCmec types IV/IVa and I-III.In vitro pharmacokinetic/pharmacodynamic models in anti-infective drug development: focus on TBDaptomycin bactericidal activity and correlation between disk and broth microdilution method results in testing of Staphylococcus aureus strains with decreased susceptibility to vancomycin.Reduced vancomycin susceptibility found in methicillin-resistant and methicillin-sensitive Staphylococcus aureus clinical isolates in Northeast China.Transcriptomic and functional analysis of an autolysis-deficient, teicoplanin-resistant derivative of methicillin-resistant Staphylococcus aureus.Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremia.Nationwide surveillance for Staphylococcus aureus with reduced susceptibility to vancomycin in KoreaHigh percentage of methicillin-resistant Staphylococcus aureus isolates with reduced susceptibility to glycopeptides in The NetherlandsVancomycin and daptomycin minimum inhibitory concentration distribution and occurrence of heteroresistance among methicillin-resistant Staphylococcus aureus blood isolates in Turkey.Mechanism of reduced vancomycin susceptibility conferred by walK mutation in community-acquired methicillin-resistant Staphylococcus aureus strain MW2Vancomycin tolerant, methicillin-resistant Staphylococcus aureus reveals the effects of vancomycin on cell wall thickeningStaphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods.Relationship of agr expression and function with virulence and vancomycin treatment outcomes in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.Detection of Staphylococcus aureus isolates with heterogeneous intermediate-level resistance to vancomycin in the United States.Association between vancomycin day 1 exposure profile and outcomes among patients with methicillin-resistant Staphylococcus aureus infective endocarditis.Rapid induction of high-level carbapenem resistance in heteroresistant KPC-producing Klebsiella pneumoniae.Clinical and microbiologic analysis of the risk factors for mortality in patients with heterogeneous vancomycin-intermediate Staphylococcus aureus bacteremia.Telavancin demonstrates activity against methicillin-resistant Staphylococcus aureus isolates with reduced susceptibility to vancomycin, daptomycin, and linezolid in broth microdilution MIC and one-compartment pharmacokinetic/pharmacodynamic models.High prevalence of isolates with reduced glycopeptide susceptibility in persistent or recurrent bloodstream infections due to methicillin-resistant Staphylococcus aureus.Clinical outcomes and molecular typing of heterogenous vancomycin-intermediate Staphylococcus aureus bacteremia in patients in intensive care unitsStaphylococcus aureus with reduced susceptibility to vancomycin.Rapid Detection of Vancomycin-Intermediate Staphylococcus aureus by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry.
P2860
Q24646621-B37299AD-AAA0-4A0B-BFB4-BCEFDB778AABQ24646677-CC696235-3F93-45F7-B4C3-BA6980F3B30AQ24650535-6D5B24AF-80FC-4EBB-B58E-302112FC943DQ26796560-21D14D2F-5A81-42AB-B734-A32D0557FE3AQ27011138-F1E5847C-247F-41DB-B2E5-668BD6A9AA16Q28727420-0BAB95D4-20D2-42CF-927D-82A3540DF59FQ30341876-D5FD98BF-2E9A-492E-9617-E982F12FC366Q30452801-78F13F7B-93F7-4F3C-A41F-3447A10501A6Q33500363-6CB079FE-D07C-4FAE-B725-621779181116Q33613735-5D791E2F-D8B5-42D0-8159-C24F67AECDFEQ33938055-0F421ADB-F569-4226-A6E6-2F2CAACAE147Q34057324-45B90AF2-0DDE-4C1D-8C28-29A2ECD3F701Q34057548-3AED7BB9-025F-4A18-9243-9F0301479A30Q34058222-1C5E2C41-ACD7-4E04-8BA1-D904AAD00799Q34108614-352462CE-817D-4CD3-BE61-E6BB07C79A7FQ34130471-32B7F5DB-60D7-4B71-9156-DA46FCB56DC9Q34157657-7A5DFE2B-1FA3-4A30-B524-F9CAE7D99996Q34463444-AAD45904-A104-4398-8FA5-4CB2D68BE416Q34477769-DECCE458-67F5-4EEE-99DA-1C367825F46EQ34591451-C9BCA906-EDB9-4462-A3F6-18295C99085EQ34721715-82D6826F-632F-485E-B198-160198E4A8EAQ34998629-B806F27F-A832-4327-A89B-C2FCDFF1962CQ35023285-E8D6C057-9EA0-4CD9-B756-7CC2CA314507Q35023343-8E17871A-2353-483C-98ED-37DADE7E739DQ35026306-A86C59B2-E574-47F7-9CA4-9FF8A0A91708Q35027895-3875ED58-863C-464C-983D-362B95B7314FQ35064413-B665F54D-4790-4C46-A207-A0CBA482AE30Q35105880-303FBF06-4A36-44FC-9F34-86A88A6C319CQ35203343-4FE3BFB1-79F6-4B2D-85FB-138B13C624A7Q35541702-911CC0F8-778E-45AA-A101-90D5C35A19BDQ35598459-B36D3952-8306-4CC9-9939-7799A5206398Q35598902-7C29AD1D-F617-47CB-82D2-3783C70F3398Q35607636-68DEB057-3FDD-4C79-81E0-DE3F7CE544B1Q35607909-5A19A637-A980-4699-8ECC-F026F131D849Q35607912-0CA87C46-181F-40FF-8053-A980B15DC6BDQ35678198-A7BB919F-F838-4DA5-BAFD-676C7220D468Q35806306-E5F0E32C-5239-4493-99BE-989908A036DBQ35819831-0CE0C55C-7A71-46F7-88DA-B1AEF6BA9F36Q35882353-6242A768-2275-4793-85CA-B420A17DBB8BQ35893439-F4FFCA48-88BF-43C7-8F2B-F679E52AB80C
P2860
A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
A modified population analysis ...... occus aureus in a UK hospital.
@en
A modified population analysis profile
@nl
type
label
A modified population analysis ...... occus aureus in a UK hospital.
@en
A modified population analysis profile
@nl
prefLabel
A modified population analysis ...... occus aureus in a UK hospital.
@en
A modified population analysis profile
@nl
P2093
P356
P1476
A modified population analysis ...... occus aureus in a UK hospital.
@en
P2093
P304
P356
10.1093/JAC/47.4.399
P407
P577
2001-04-01T00:00:00Z